The role of cefamandole in the treatment of Haemophilus influenzae infections in infants and children

Paul S. Lietman, Parvin H. Azimi, Patricia A. Chase

Research output: Contribution to journalArticle

Abstract

Forty patients with suspected non-CNS Hib infections were treated with cefamandole at a dosage of 100 to 150 mg/kg/day. Hib was isolated from 19 patients; three of the isolates were Blac+. All patients responded well without complications exept for two children, both infected with Blac+ organisms, who subsequently developed maningitis, one three weeks following treatment for buccal cellulitis and bacteremia, the other while being treated with cefamandole for empyema. All strains of Hib were niformly susceptible to cefamandole regardless of beta-lactamase production when tested with an inoculum of 104 cfu/ml. With 107 cfu/ml an inoculum effect was seen which ws more pronounced with Blac+ strains. Moreoveer, "heavy" inoculum of Blac+ strains inactivated cefamandole in four to eight hours resulting in bacterial overgrowth. Similar results were obtained for ampicillin; chloramphenicol killed all strains regardless of inoculum size or beta-lactamase production. We conclude that cefamandole may be hydrolyzed by Blac+ organisms when present in large numbers, resulting in treatment failure. Extreme care should be taken in the choice of cefamandole for young infants with Hib infections, since this antibiotic neither cures nor prevents meningitis.

Original languageEnglish (US)
Pages (from-to)995-1000
Number of pages6
JournalThe Journal of pediatrics
Volume98
Issue number6
DOIs
StatePublished - Jun 1981

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this